Terri B Hyde

Summary

Affiliation: Centers for Disease Control and Prevention
Country: USA

Publications

  1. doi request reprint The impact of new vaccine introduction on immunization and health systems: a review of the published literature
    Terri B Hyde
    Centers for Disease Control and Prevention, Atlanta, GA 30333, USA
    Vaccine 30:6347-58. 2012
  2. doi request reprint Critical issues in implementing a national integrated all-vaccine preventable disease surveillance system
    Terri B Hyde
    Global Immunization Division, Us centers for Disease Control and Prevention CDC, 1600 Clifton Road NE, Atlanta, GA 30333, USA
    Vaccine 31:C94-8. 2013
  3. ncbi request reprint Measles outbreak in the Republic of the Marshall Islands, 2003
    Terri B Hyde
    Viral Vaccine Preventable Diseases Branch, National Immunization Program, NIP, Centers for Disease Control and Prevention, CDC, Atlanta, GA 30333, USA
    Int J Epidemiol 35:299-306. 2006
  4. ncbi request reprint Rubella immunity levels in the United States population: has the threshold of viral elimination been reached?
    Terri B Hyde
    National Center for Immunization and Respiratory Diseases proposed, Centers for Disease Control and Prevention, Atlanta, GA 30333, USA
    Clin Infect Dis 43:S146-50. 2006
  5. pmc Laboratory confirmation of measles in elimination settings: experience from the Republic of the Marshall Islands, 2003
    Terri B Hyde
    Global Immunization Division, Centers for Disease Control and Prevention, Atlanta, GA, United States of America
    Bull World Health Organ 87:93-8. 2009
  6. doi request reprint Laboratory characterization of measles virus infection in previously vaccinated and unvaccinated individuals
    Carole J Hickman
    Division of Viral Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia 30333, USA
    J Infect Dis 204:S549-58. 2011
  7. doi request reprint Review of cytomegalovirus seroprevalence and demographic characteristics associated with infection
    Michael J Cannon
    National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention CDC, Atlanta, GA 30329, USA
    Rev Med Virol 20:202-13. 2010
  8. ncbi request reprint Seroprevalence of measles antibody in the US population, 1999-2004
    Geraldine M McQuillan
    Division of Health and Nutrition Examination Surveys, National Center for Health Statistics, Centers for Disease Control and Prevention, 3311 Toledo Road, Hyattsville, MD 20782, USA
    J Infect Dis 196:1459-64. 2007
  9. doi request reprint Review of cytomegalovirus shedding in bodily fluids and relevance to congenital cytomegalovirus infection
    Michael J Cannon
    National Center on Birth Defects and Developmental Disabilities, Atlanta, GA, USA
    Rev Med Virol 21:240-55. 2011
  10. doi request reprint Impact of conjugate vaccine on transmission of antimicrobial-resistant Streptococcus pneumoniae among Alaskan children
    Sarah Y Park
    From the Office of Workforce and Career Development, Centers for Disease Control and Prevention CDC, Atlanta, GA, USA
    Pediatr Infect Dis J 27:335-40. 2008

Detail Information

Publications16

  1. doi request reprint The impact of new vaccine introduction on immunization and health systems: a review of the published literature
    Terri B Hyde
    Centers for Disease Control and Prevention, Atlanta, GA 30333, USA
    Vaccine 30:6347-58. 2012
    ..Future evaluations of new vaccine introductions should include the systematic and objective assessment of the impacts on a country's immunization system and broader health system, especially in lower-income countries...
  2. doi request reprint Critical issues in implementing a national integrated all-vaccine preventable disease surveillance system
    Terri B Hyde
    Global Immunization Division, Us centers for Disease Control and Prevention CDC, 1600 Clifton Road NE, Atlanta, GA 30333, USA
    Vaccine 31:C94-8. 2013
    ..We describe the process of developing operational guidance for ministries of health to implement such an integrated surveillance system for multiple VPDs...
  3. ncbi request reprint Measles outbreak in the Republic of the Marshall Islands, 2003
    Terri B Hyde
    Viral Vaccine Preventable Diseases Branch, National Immunization Program, NIP, Centers for Disease Control and Prevention, CDC, Atlanta, GA 30333, USA
    Int J Epidemiol 35:299-306. 2006
    ..Reported 1-dose measles vaccine coverage among children aged 12-23 months varied widely (52-94%) between 1990 and 2000...
  4. ncbi request reprint Rubella immunity levels in the United States population: has the threshold of viral elimination been reached?
    Terri B Hyde
    National Center for Immunization and Respiratory Diseases proposed, Centers for Disease Control and Prevention, Atlanta, GA 30333, USA
    Clin Infect Dis 43:S146-50. 2006
    ..8% to 88.0%; P=.84). In 1999-2004, population rubella immunity levels were at or above the modeled threshold for elimination of rubella virus transmission. Increases in immunity levels are consistent with vaccination efforts...
  5. pmc Laboratory confirmation of measles in elimination settings: experience from the Republic of the Marshall Islands, 2003
    Terri B Hyde
    Global Immunization Division, Centers for Disease Control and Prevention, Atlanta, GA, United States of America
    Bull World Health Organ 87:93-8. 2009
    ....
  6. doi request reprint Laboratory characterization of measles virus infection in previously vaccinated and unvaccinated individuals
    Carole J Hickman
    Division of Viral Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia 30333, USA
    J Infect Dis 204:S549-58. 2011
    ..These parameters may represent useful biomarkers for classification of SVF cases that previously could not be confirmed as such using routine laboratory diagnostic techniques...
  7. doi request reprint Review of cytomegalovirus seroprevalence and demographic characteristics associated with infection
    Michael J Cannon
    National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention CDC, Atlanta, GA 30329, USA
    Rev Med Virol 20:202-13. 2010
    ..Future vaccine or educational campaigns to prevent primary infection in pregnant women may need to be tailored to suit the needs of different populations...
  8. ncbi request reprint Seroprevalence of measles antibody in the US population, 1999-2004
    Geraldine M McQuillan
    Division of Health and Nutrition Examination Surveys, National Center for Health Statistics, Centers for Disease Control and Prevention, 3311 Toledo Road, Hyattsville, MD 20782, USA
    J Infect Dis 196:1459-64. 2007
    ..Testing for measles antibody was included in the National Health and Nutrition Examination Survey (NHANES), a nationally representative survey, conducted during 1999-2004...
  9. doi request reprint Review of cytomegalovirus shedding in bodily fluids and relevance to congenital cytomegalovirus infection
    Michael J Cannon
    National Center on Birth Defects and Developmental Disabilities, Atlanta, GA, USA
    Rev Med Virol 21:240-55. 2011
    ..Higher CMV viral load at birth also consistently correlated with the presence of symptoms of congenital CMV at birth. Published 2011. This article is a US Government work and is in the public domain in the USA...
  10. doi request reprint Impact of conjugate vaccine on transmission of antimicrobial-resistant Streptococcus pneumoniae among Alaskan children
    Sarah Y Park
    From the Office of Workforce and Career Development, Centers for Disease Control and Prevention CDC, Atlanta, GA, USA
    Pediatr Infect Dis J 27:335-40. 2008
    ..The impact of heptavalent pneumococcal conjugate vaccine (PCV7) on transmission of antimicrobial-resistant Streptococcus pneumoniae is an important concern for countries considering PCV7 introduction...
  11. ncbi request reprint Impact of a conjugate vaccine on community-wide carriage of nonsusceptible Streptococcus pneumoniae in Alaska
    Matthew R Moore
    Division of Applied Public Health Training, Epidemiology Program Office, National Center for Infectious Diseases, Centers for Disease Control and Prevention, 1600 Clifton Road NE, Atlanta, GA 30333, USA
    J Infect Dis 190:2031-8. 2004
    ..Antimicrobial resistance among pneumococci has increased in recent years and complicates treatment. The introduction of heptavalent pneumococcal conjugate vaccine (PCV7) could reduce acquisition of antimicrobial-resistant pneumococci...
  12. pmc Integrating pneumonia prevention and treatment interventions with immunization services in resource-poor countries
    Adam L Cohen
    National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, GA 30333, USA
    Bull World Health Organ 90:289-94. 2012
    ....
  13. doi request reprint Cytomegalovirus seroconversion rates and risk factors: implications for congenital CMV
    Terri B Hyde
    National Center for Immunizations and Respiratory Diseases, Centers for Disease Control and Prevention CDC, Atlanta, GA 30329, USA
    Rev Med Virol 20:311-26. 2010
    ..The relatively low rate of CMV seroconversion in most populations is encouraging for behavioural interventions and for vaccine strategies attempting to prevent infection during pregnancy...
  14. pmc Considerations for oral cholera vaccine use during outbreak after earthquake in Haiti, 2010-2011
    Kashmira A Date
    Centers for Disease Control and Prevention, Atlanta, Georgia 30333, USA
    Emerg Infect Dis 17:2105-12. 2011
    ..Use of OCVs is an option for cholera control; guidelines for their appropriate use in epidemic and emergency settings are urgently needed...
  15. ncbi request reprint Trends in incidence and antimicrobial resistance of early-onset sepsis: population-based surveillance in San Francisco and Atlanta
    Terri B Hyde
    Active Bacterial Core surveillance of the Emerging Infections Program Network, Division of Bacterial and Mycotic Diseases, National Center for Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia 30333, USA
    Pediatrics 110:690-5. 2002
    ..The objective of this study was to determine trends in the incidence of early-onset sepsis caused by organisms other than group B streptococcus in the era of antimicrobial prophylaxis...
  16. pmc Coronavirus antibodies in bat biologists
    Lauren J Stockman
    Emerg Infect Dis 14:999-1000. 2008